All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
The AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Catch up with our live twitter coverage from the National Cancer Research Institute 4th AML academy 2022 congress.
What are the updates from the NCRI AML18 and AML19 clinical trials?
During the 4th NCRI AML Academy Meeting, the AML Hub was pleased to speak to Nigel Russell, Guy’s and St Thomas’ NHS Foundation Trust, London, UK. We asked, What are the updates from...
What does the future hold for patients with relapsed AML?
During the 4th NCRI AML Academy Meeting, the AML Hub was pleased to speak to Pramila Krishnamurthy, King’s College Hospital NHS Foundation Trust, London, UK. We asked, What does the future...
Subscribe to get the best content related to AML delivered to your inbox